Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer

por Garrett, C R, Hassabo, H M, Bhadkamkar, N A, Wen, S, Baladandayuthapani, V, Kee, B K, Eng, C, Hassan, M M
Publicado 2012

PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers

por Dumbrava, E.E., Call, S.G., Huang, H.J., Stuckett, A.L., Madwani, K., Adat, A., Hong, D.S., Piha-Paul, S.A., Subbiah, V., Karp, D.D., Fu, S., Naing, A., Tsimberidou, A.M., Moulder, S.L., Koenig, K.H., Barcenas, C.H., Kee, B.K., Fogelman, D.R., Kopetz, E.S., Meric-Bernstam, F., Janku, F.
Publicado 2021